Status:
COMPLETED
The Influence of Personal Care Products on the Skin Microbiome
Lead Sponsor:
University of California, Davis
Conditions:
Microbiome
Eligibility:
FEMALE
20-45 years
Phase:
NA
Brief Summary
To evaluate whether personal care products shift the skin microbiome bacteria and diversity after a week of daily use.
Detailed Description
Studies have shown that microbiome is important in skin conditions such as eczema, rosacea, acne, and many other skin conditions. Personal care products are widely used on a daily basis but it is not ...
Eligibility Criteria
Inclusion
- Females, aged 20-45 (limiting to females so that there is not heterogeneity with the influence of hormones. Also, females are a much larger user base of personal care products)
- Individuals in good general health
- Individuals free of any dermatological or systemic disorder, which would interfere with the results, at the discretion of the investigator
- Individuals who have participated in any other clinical studies using the same test sites (face) in the past 14 days
Exclusion
- Individuals who have been on any topical antibiotic for the past one month or oral antibiotic therapy for the past 2 months or are currently on any antibiotic therapy
- Individuals who have history of acute or chronic disease that would likely interfere with or increase the risk on study participation at the discretion of the investigator
- Individuals with active (flaring) disease or chronic skin allergies (atopic dermatitis/eczema) or those who have recently undergone treatment for skin cancer (within the last 12 months) in the area of testing on the nose and the cheeks
- Female volunteers who are pregnant or are actively nursing
- Female volunteers who have started a new hormonal birth control agent or switched to a hormonal birth control agent within the past 60 days
- Individuals who have had any medical or cosmetic procedure, such as laser resurfacing, or plastic surgery to the test site (face) within the last 6 months. This includes botulinum toxin, dermal fillers, collagen or other similar cosmetic procedure
- Individuals who are currently using or during the past 30 days have used a retinoid such as Retin A, or other Rx/over the counter (OTC) Retinyl A or currently using or during the past 14 days have used hydroquinone (skin lightening)
- Individuals with a known history of hypersensitivity to any ingredients to the cosmetic agent that is being assessed
- Individuals with self-reported oily skin that may predispose them to acne form breakouts (at the discretion of the investigator)
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 6 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03819179
Start Date
December 1 2017
End Date
February 6 2018
Last Update
January 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Department of Dermatology, Clinical Trials Unit
Sacramento, California, United States, 95816